Treatment of Dopamine Agonist-induced Augmentation with a D1 Receptor Blocker in Patients with Restless Legs Syndrome (RLS)

NCBiotech Grants & Loans

See the full listing of all NCBiotech grants and loans awarded since July 2012.

Organization
East Carolina University
Award Date
Award Amount
100,000
Program Name
Biotechnology Innovation Grant
Program Category
Research and Equipment Support
Principal Investigator
Stefan Clemens
Fiscal Year
2016
Region
Eastern
Project Description: Restless Leg Syndrome (RLS) is a life-long neurological disorder that affects an estimated 10-20 million Americans. Treatment for RLS is centered on dopamine drugs that are initially effective, but over time lose their efficacy. We propose clinical testing of a new therapy that will overcome this loss of efficacy.
scroll back to top of page